News
Article
Author(s):
Explore the standout moments and expert insights from Dermatology Times' Cutaneous Connection podcast episodes in 2024.
This year, Dermatology Times' Cutaneous Connection podcast brought listeners closer to the latest trends, innovations, and expert perspectives in dermatology. From in-depth discussions on cutting-edge treatments to practical advice for clinicians, each episode offered valuable insights to help navigate the evolving landscape of skin care. As 2024 draws to a close, we’re revisiting the most impactful episodes and the conversations that defined the year.
Raj Chovatiya, MD, PhD, gave a sneak peek of what to expect in atopic dermatitis education at the 2024 American Academy of Dermatology (AAD) Meeting in San Diego, California March 8-12. Since the 2023 meeting, the AAD had released new guidelines to treat the condition.
Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, caught up with us at the 2024 American Academy of Dermatology Meeting to decode new atopic dermatitis treatment data and how that translates to personalized options for patients.
Brian Kim, MD, had an unexpected attendee at one of his AAD sessions and delved into what's new, what's now, and what's next in atopic dermatitis management.
Bradley Burnam, the founder and CEO of Turn Therapeutics, discussed his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
Nanette Silverberg reviewed the key highlights from her vitiligo sessions at the 2024 Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, also known this year as RAVE. Dr Silverberg is the chief of pediatric dermatology for the Mount Sinai Health System and site director of pediatric and adolescent dermatology at Mount Sinai West and Mount Sinai Beth Israel in New York, as well as the conference chair of the vitiligo portion of RAVE. At the conference, Dr Silverberg presented “Topical Therapeutics for Vitiligo” and “Excellence in Vitiligo Clinical Practice.” Silverberg shared the top takeaways from her sessions that clinicians can utilize in their practice.
James Song, MD, FAAD, chief medical officer and director of clinical research at Frontier Dermatology in Seattle, Washington, delved into the complexities and advancements in treating atopic dermatitis (AD). Song highlighted the challenges of transitioning patients from topical to systemic therapies, emphasizing the need for timely conversations and patient comfort. He discussed the efficacy and rapid response of oral JAK inhibitors compared to biologics, while addressing safety concerns and the necessity for blood monitoring. Song also explored patient-specific factors in treatment choices, the importance of systemic therapy for moderate to severe cases, and the promise of emerging biologics targeting IL-31 and OX40 pathways.
Albert Yan, MD, FAAP, FAAD, research director at the Children's Hospital of Philadelphia, professor at the Perelman School of Medicine, and executive at Inner Archways LLC, discussed pearls and insights from his lecture presented at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. Yan spoke on artificial intelligence and ChatGPT and the balance of positive yet harmful potential of AI chatbots in medicine.
Drs Vikash Oza, MD, and James Treat, MD, delved into the topic, “Does Food Trigger Eczema?” Oza, an associate professor of dermatology and pediatrics and the director of pediatric dermatology at NYU in New York City, and Treat, a professor of clinical pediatrics and dermatology at the Perelman School of Medicine and an affiliate of the Children’s Hospital of Philadelphia, participated in 1 of 3 “Great Debates in Peds Derm” at the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada. The duo shared insights from their debate and pearls for clinicians related to allergy and eczema.
We caught up with Peter Lio, MD, a clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, at the 2024 Society for Pediatric Dermatology Annual Meeting. Lio presented a session on changing the disease course in pediatric atopic dermatitis, alongside Amy Paller, MD. We dived into the highlights of their talk, the role of disease progression, and the exciting pipeline ahead.
Itisha S. Jefferson, a medical student, patient advocate, and one of the co-founders of the Scarring Alopecia Foundation's medical student program, shared the inspiring advocacy journey and team effort behind the approval of ICD-10 codes for scarring alopecias.
Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.